Modern biopharma firms are adapting their R&D investment strategies in response to challenges such as the impending $300 ...

Nigel Farage's spokesperson has denied allegations that the Reform leader could be in breach of parliamentary rules after a report that he failed to declare receiving benefits from an ally. Watch ...